Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06259097 · ClinicalTrials.gov registry record · Phase 3
Different Medications to Induce Labor
A Phase 3 study of Pregnancy and Labor, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 300
- Enrollment target
- 2
- Study locations
NCT06259097: Recruiting Phase 3 study of Pregnancy and Labor, sponsored by Icahn School of Medicine at Mount Sinai.
NCT06259097 is a Phase 3 study of Pregnancy and Labor that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 300 participants, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (66% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06259097, a Phase 3 study of Pregnancy and Labor, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a randomized controlled trial examining whether the use of misoprostol or pitocin, in combination with a foley catheter, is more effective at inducing labor in patients with a gravid BMI that is considered obese.
Primary Outcome
Simple measure calculating time from start of induction until delivery of neonate.
Interventions
- DRUG Misoprostol
- DRUG Pitocin
Study Locations (2)
New York
- Mount Sinai Hospital - New York
- Bronx Care Health System - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-07-02 |
| Est. Completion | 2026-04 |
| Phase | Phase 3 |
What NCT06259097 shows while recruiting
NCT06259097 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (66% lower).
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Misoprostol is the first listed.
NCT06259097 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06259097 about?
NCT06259097 is a clinical study titled "Different Medications to Induce Labor". This is a randomized controlled trial examining whether the use of misoprostol or pitocin, in combination with a foley catheter, is more effective at inducing labor in patients with a gravid BMI that is considered obese.
What is the current status of trial NCT06259097?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2024-07-02. Estimated completion is 2026-04.
What conditions does trial NCT06259097 study?
This clinical trial studies the following conditions: Pregnancy, Labor.
What interventions are being tested in trial NCT06259097?
The interventions under investigation include: Misoprostol (DRUG), Pitocin (DRUG).
Who is sponsoring clinical trial NCT06259097?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06259097 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06259097's enrollment target sits among peer trials
300 68th of 191 higher than 120 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ropivacaine and Fentanyl for Labor Epidural Initiation
RECRUITING · Phase 3
-
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
RECRUITING · Phase 3
-
A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
COMPLETED · Phase 3
-
The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants
COMPLETED · Phase 3
-
Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)
COMPLETED · Phase 3
-
Comparison of Foley Balloon With or Without Traction for the Cervical Ripening
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI